-
News Summary
Wednesday, January 12, 2011 - 10:43am | 179Grain futures surged after the US Department of Agriculture (USDA) reduced its 2010 projections for corn, soybean and wheat production. USDA lowered its corn production estimates to 12.45 billion bushels. Corn for March delivery rose 4.9% to $6.37 a bushel, while Soybeans for March advanced 5.2% to...
-
Short Interest Slides on Healthcare Names (DNEX, BEC, PLL)
Wednesday, January 12, 2011 - 10:38am | 224Jefferies & Company is out with a research report this morning, where it notes that median short interest for Diagnostic and Research Supplies stocks fell 1% and 7%, respectively, in the second half of December. This compares to a 5% absolute decline for both the NYSE and NASDAQ. Short interest...
-
J.P. Morgan Reiterates Neutral Rating on Thoratec Corp. (THOR)
Wednesday, January 12, 2011 - 10:22am | 165J.P. Morgan is out with a research report this morning, where it reiterates its Neutral rating on Thoratec Corp. (NASDAQ: THOR); it has a $30.00 price target on the stock. The JPM analysts cited the company's recent presentation at the JPM Healthcare Conference, where CEO Gary Burbach devoted the...
-
Antares Pharma to Initiate Clinical Trial of VIBEX
Wednesday, January 12, 2011 - 10:01am | 55Antares Pharma, Inc. (NYSE: AIS) today announced plans to conduct a clinical trial of the Company's proprietary VIBEX™ MTX product being developed for the treatment of rheumatoid arthritis following clearance of an Investigational New Drug application filed with the U.S. Food and Drug...
-
Piper Jaffray Overweight On Gen-Probe (GPRO)
Wednesday, January 12, 2011 - 8:29am | 141Piper Jaffray has an Overweight rating and a $68 price target on shares of Gen-Probe (NASDAQ: GPRO). In a note sent to clients, Piper Jaffray writes, "Our latest round of CT/NG channel checks show a sequential volume increase of 0.8%, continuing to improve vs. our recent checks (2Q10: -1.1%, 3Q10...
-
CIRC (Circulation Improving Resuscitation Care) Trial Concludes Successfully
Wednesday, January 12, 2011 - 8:14am | 445ZOLL Medical Corporation (NASDAQ: ZOLL), a manufacturer of medical devices and related software solutions, announced today the successful conclusion of the ZOLL-sponsored CIRC trial. The trial's Data Safety Monitoring Board (DSMB) closed enrollment when an analysis of the data showed the load-...
-
Oppenheimer Discusses Mindray Medical (MR)
Wednesday, January 12, 2011 - 8:14am | 112Oppenheimer has a research report on Mindray Medical International Limited (NYSE: MR). It has a Perform rating on shares. In the research note Oppenheimer writes, "1) Management views the 16% revenue growth guidance in 2011 as deliverable, assuming double-digit growth in the developed markets,...
-
Mindray's Prelim Results Impress - Analyst Blog
Tuesday, January 11, 2011 - 6:32pm | 604Leading Chinese medical devices maker Mindray Medical International Limited (MR) has announced selected preliminary results for fiscal 2010. The Shenzhen-based company expects its revenues for the year to grow 10% year over year to roughly $703 million. Moreover, the company estimates adjusted net...
-
Mindray's Prelim Results Impress - Analyst Blog
Tuesday, January 11, 2011 - 6:09pm | 604Leading Chinese medical devices maker Mindray Medical International Limited (MR) has announced selected preliminary results for fiscal 2010. The Shenzhen-based company expects its revenues for the year to grow 10% year over year to roughly $703 million. Moreover, the company estimates adjusted net...
-
Wright Medical Group, Inc. Announces IDE Approval for Calcaneal Stem Fixation
Tuesday, January 11, 2011 - 5:34pm | 67Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that it has received approval from the U.S. Food and Drug Administration to conduct an Investigational Device Exemption clinical study to investigate use of the INBONE Total Ankle Replacement with Calcaneal Stem for treatment of end stage...
-
Stryker Rises on Buoyant View - Analyst Blog
Tuesday, January 11, 2011 - 3:01pm | 1033Shares of orthopedic devices major Stryker (SYK) rose following the company's upbeat guidance and encouraging fourth-quarter fiscal 2010 revenues, which topped Street expectations. The company is slated to release final results for the quarter and fiscal 2010 on January 25, 2011. Sales Beat...
-
Stryker Rises on Buoyant View - Analyst Blog
Tuesday, January 11, 2011 - 2:19pm | 1033Shares of orthopedic devices major Stryker (SYK) rose following the company's upbeat guidance and encouraging fourth-quarter fiscal 2010 revenues, which topped Street expectations. The company is slated to release final results for the quarter and fiscal 2010 on January 25, 2011. Sales Beat...
-
Tuesday's Put/Call Ratio Leaders (ASNA, AON, BSX, HOG, IBN)
Tuesday, January 11, 2011 - 1:10pm | 84Here is a quick peek at stocks that have abnormally high daily put/call ratios today relative to their average…. 1. Ascena Retail Group (NASDAQ: ASNA) 6,763 puts, 4 calls 2. Aon Corp. (NYSE: AON) 2,540 puts, 13 calls 3. Boston Scientific Corp. (NYSE: BSX) 9,125 puts, 135 calls 4. Harley Davidson (...
-
Wunderlich Securities Reiterates Hold Rating on Stryker Corporation (SYK)
Tuesday, January 11, 2011 - 10:55am | 116Wunderlich Securities is out with a research report this morning, where it reiterates its Hold rating on Stryker Corporation (NYSE: SYK); it has a $56.00 price target on the stock, up from $54.00. The WS analysts cited SYK's pre-announced Q4 earnings results, which were “solid.” The company also...
-
Oppenheimer Comments On Stryker Earnings Announcement
Tuesday, January 11, 2011 - 10:32am | 154Stryker (NYSE: SYK) pre-announced 4Q 2010 revenue of $1.995B, ahead of Oppenheimer/Street estimates, led by continued strength in MedSurg and accelerated growth in hips/knees. Management raised ex-charge EPS guidance for FY10 to $3.31-3.33 from $3.27-3.30. According to Oppenheimer, for FY11, SYK...